Alpha DNA Investment Management »

Halozyme Therapeutics shares owned by Alpha DNA Investment Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Alpha DNA Investment Management from 13F filings

Historical chart of Alpha DNA Investment Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Alpha DNA Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Alpha DNA Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $539k 9.4k 57.24
2024-06-30 $444k 8.5k 52.36
2024-03-31 $272k 6.7k 40.68
2021-03-31 $4.0k 109 36.70